The Tuberculosis Drug Accelerator at year 10: what have we learned?

Jul 7, 2021

1 min read

The Tuberculosis Drug Accelerator, an experiment designed to facilitate collaboration in tuberculosis drug discovery by breaking down barriers among competing labs and institutions, has reached a 10-year landmark. We review the consortium’s achievements, advantages and limitations and advocate for the application of similar models to other diseases. Read here

Recent Posts

See All

Long a dream, its now real: a fast and accurate TB test that doesn't need phlegm.

Phlegm remains the most common test for determining if an individual has TB - a practice that has not changed much since the 1800s and poses many challenges for both patients and health care professio

New free eLearning Programme with The Union: 'Drug-Resistant Tuberculosis: From Clinical to Programmatic'

The International Union Against Tuberculosis and Lung Disease (The Union) is offering a free and accessible course created for clinicians and program managers who are working or planning to work with

Trials to watch: Phase III TB vaccines and MDR-TB treatments

After years without much advancement in new TB drug trials, a vaccine and two treatments are progressing through late-stage studies. As researchers predict the number of TB cases in the 16 major marke

Comments

Couldn’t Load Comments

It looks like there was a technical problem. Try reconnecting or refreshing the page.